Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum.
- 1 August 1985
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 82 (16) , 5470-5474
- https://doi.org/10.1073/pnas.82.16.5470
Abstract
Lymphocyte-mediated lysis of cells of the Raji, Daudi, Jijoye, and Bjab lines was elevated when fresh human serum was added to the assay. A higher proportion of effector-target conjugates was observed in the presence of human serum. In similar experiments lysis of 1301, Rael, and P3HR-1 cells was unaltered. All cell lines activated the alternative pathway of complement but they varied in the expression of receptors for complement component 3 (C3) and in the ability to fix the C3 cleavage products on their membrane. The enhancement of lysis in the presence of human serum occurred only with those cells that bound C3. This characteristic was correlated to the expression of C3 receptors. Analysis of the nature of the deposited C3 was performed with Raji cells. Raji cells exposed to human serum bound C3b as indicated by the immunoadherence test. The C3b was further processed to C3bi, because the immunoadherence declined with time and conjugate formation increased with Daudi cells, which carry the C3 receptors CR2 and CR3. This suggests that in the lytic assay lymphocytes with C3bi receptors are recruited in the presence of human serum. We assume that the bridge of C3 molecules between targets and effectors increases the avidity of their interaction.Keywords
This publication has 26 references indexed in Scilit:
- Complement-dependent cellular cytotoxicity due to alternative pathway C3 activation by the target cell membraneCellular Immunology, 1984
- Substances that can trigger activation of the alternative pathway of complement have anti-melanoma activity in miceInternational Journal of Cancer, 1984
- Analysis of gp140, a C3b‐binding membrane component present on Raji cells: a comparison with factor HEuropean Journal of Immunology, 1984
- ACTIVATION OF CYTO-TOXIC ACTIVITY OF HUMAN-BLOOD LYMPHOCYTES BY TUMOR-PROMOTING COMPOUNDS1984
- C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface.The Journal of Immunology, 1983
- Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.The Journal of Experimental Medicine, 1983
- Complement Receptor Distinguishes between Two Subsets of Large Granular Lymphocytes with Different Natural Killer Activity and Cytochemical and Ultrastructural FeaturesScandinavian Journal of Immunology, 1983
- The human C3b receptorSpringer Seminars in Immunopathology, 1983
- C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.The Journal of Immunology, 1983
- Complement And Tumor ImmunologyAdvances in Cancer Research, 1971